中药治疗卒中后疲劳的定量分析:Meta分析与用药规律研究
本研究整合Meta分析与用药规律分析,系统评价中药治疗卒中后疲劳的疗效。用药规律分析涉及15首独特中药复方、52味中药,高频药物为黄芪、当归、川芎,核心功效为补虚与活血化瘀。
要点
- 中药可显著减轻卒中后疲劳严重程度,并改善生活质量、运动功能与情绪障碍。
- 高频药物为黄芪、当归、川芎,药性多温或微温,味甘辛,归脾、肝、心经。
- 核心中医治则为补虚与活血化瘀,证据尚需大规模多中心随机对照试验验证。
核心结论
- 本研究为中药用于卒中后疲劳的临床管理提供了初步证据,并突出了关键中药与核心中医治疗策略。
- 仍需进一步开展大规模、多中心随机对照试验以强化证据基础,促进中药融入全球卒中后疲劳临床实践。
研究设计与样本
- Meta分析使用Review Manager 5.4,采用漏斗图与Egger检验评估潜在发表偏倚。
- 用药规律分析从使用频率、性味、归经及中药功效层次聚类方面分析15首独特中药复方中的52味中药。
主要发现
- Meta分析显示中药显著减轻疲劳严重程度(以疲劳严重程度量表测量)。
- 证据提示中药改善生活质量、运动功能与情绪障碍。
- 未检测到显著发表偏倚。
- 用药规律分析识别52味中药,高频成分包括黄芪、当归、川芎。
- 药性多温或微温,味甘辛,归脾、肝、心经,体现补虚与活血化瘀核心功效。
临床怎么用
- 临床可考虑将中药用于卒中后疲劳管理,重点关注黄芪、当归、川芎等高频药物及补虚活血化瘀治则。
- 应用时需结合患者具体证候与中药性味归经特点进行辨证配伍。
局限性
- 研究结论为初步证据,仍需大规模、多中心随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-stroke fatigue (PSF) is a common and distressing condition among stroke survivors. Chinese herbal medicine (CHM) is frequently utilized in China to manage PSF. However, robust synthesized evidence supporting its efficacy remains limited. This study integrates meta-analysis with medication pattern analysis to establish a comprehensive evidence base for the rational clinical application of CHM in PSF treatment. METHODS: Relevant RCTs were retrieved from eight databases-including PubMed, Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure Chinese Biomedical Database (SinoMed), Chinese Scientific Journal Database (VIP), and Wanfang-up to March 2026. Meta-analysis was performed using Review Manager 5.4, while funnel plot and Egger's test were utilized to evaluate potential publication bias. Furthermore, we analyzed medication pattern in terms of usage frequency, properties, flavors, meridian tropism, and hierarchical cluster of Traditional Chinese Medicine actions of Chinese medicinal materials. RESULTS: Nineteen trials involving 1,474 patients were included. Meta-analysis indicated that CHM significantly alleviated fatigue severity, as measured by fatigue severity scale. Evidence also suggested that CHM improved quality of life, motor function, and mood disorders. No significant publication bias was detected. Medication pattern analysis of 15 unique CHM formulas identified 52 Chinese medicinal materials, with high-frequency ingredients including Astragali radix, Angelicae sinensis radix, Chuanxiong rhizoma. The medicinal profiles were characterized by warm or slightly warm natures, sweet and pungent flavors, and tropism toward the spleen, liver, and heart meridians, reflecting core efficacies of tonifying deficiency and activating blood to resolve stasis. CONCLUSION: This study provides preliminary evidence for the clinical consideration of CHM in the management of post-stroke fatigue and highlights key Chinese medicinal materials and core TCM therapeutic strategies. However, further large-scale, multicenter randomized controlled trials are warranted to strengthen the evidence base and facilitate the integration of CHM into global clinical practice for post-stroke fatigue. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261356354.
引用
- Liu Y, Wang J, Wu X, et al. Quantitative analysis of Chinese herbal medicine for post-stroke fatigue: a meta-analysis and medication pattern study. Front Pharmacol. 2026. PMID: 42602211. doi:10.3389/fphar.2026.1880065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。